A. Szczepaniak, L. Gil, S. Giebel, G. Helbig, T. Wróbel, J. Zaucha, B. Budziszewska, A. Wierzbowska
{"title":"应用文托克乐联合阿扎胞苷治疗新诊断急性髓性白血病患者不适合强化化疗的实际方面","authors":"A. Szczepaniak, L. Gil, S. Giebel, G. Helbig, T. Wróbel, J. Zaucha, B. Budziszewska, A. Wierzbowska","doi":"10.5603/hcp.a2022.0018","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":284891,"journal":{"name":"Hematology in Clinical Practice","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Practical aspects of the use of ventoclax in combination with azacitidine for the treatment of newly diagnosed acute myeloid leukaemia in patients ineligible for intensive chemotherapy\",\"authors\":\"A. Szczepaniak, L. Gil, S. Giebel, G. Helbig, T. Wróbel, J. Zaucha, B. Budziszewska, A. Wierzbowska\",\"doi\":\"10.5603/hcp.a2022.0018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":284891,\"journal\":{\"name\":\"Hematology in Clinical Practice\",\"volume\":\"8 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology in Clinical Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/hcp.a2022.0018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology in Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/hcp.a2022.0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Practical aspects of the use of ventoclax in combination with azacitidine for the treatment of newly diagnosed acute myeloid leukaemia in patients ineligible for intensive chemotherapy